User profiles for Shuaidong Huo

Shuaidong Huo (霍帅东)

Xiamen University, China
Verified email at xmu.edu.cn
Cited by 5798

Size-Dependent Localization and Penetration of Ultrasmall Gold Nanoparticles in Cancer Cells, Multicellular Spheroids, and Tumors in Vivo

K Huang, H Ma, J Liu, S Huo, A Kumar, T Wei… - ACS …, 2012 - ACS Publications
This work demonstrated that ultrasmall gold nanoparticles (AuNPs) smaller than 10 nm display
unique advantages over nanoparticles larger than 10 nm in terms of localization to, and …

Carbon-dot-supported atomically dispersed gold as a mitochondrial oxidative stress amplifier for cancer treatment

…, X Ye, Q Zhou, X Chen, X Tan, S Yao, S Huo… - Nature …, 2019 - nature.com
Mitochondrial redox homeostasis, the balance between reactive oxygen species and
antioxidants such as glutathione, plays critical roles in many biological processes, including …

Enhanced tumor accumulation of sub‐2 nm gold nanoclusters for cancer radiation therapy

…, YM Sun, PX Liu, J Zhao, S Huo… - Advanced …, 2014 - Wiley Online Library
A new type of metabolizable and efficient radiosensitizers for cancer radiotherapy is
presented by combining ultrasmall Au nanoclusters (NCs, <2 nm) with biocompatible coating …

Ultrasmall gold nanoparticles as carriers for nucleus-based gene therapy due to size-dependent nuclear entry

S Huo, S Jin, X Ma, X Xue, K Yang, A Kumar… - ACS …, 2014 - ACS Publications
The aim of this study was to determine the size-dependent penetration ability of gold nanoparticles
and the potential application of ultrasmall gold nanoparticles for intranucleus delivery …

The interplay of size and surface functionality on the cellular uptake of sub-10 nm gold nanoparticles

Y Jiang, S Huo, T Mizuhara, R Das, YW Lee, S Hou… - ACS …, 2015 - ACS Publications
Correlation of the surface physicochemical properties of nanoparticles with their interactions
with biosystems provides key foundational data for nanomedicine. We report here the …

Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance

…, P Posocco, X Liu, Q Cheng, S Huo… - Proceedings of the …, 2015 - National Acad Sciences
Drug resistance and toxicity constitute challenging hurdles for cancer therapy. The application
of nanotechnology for anticancer drug delivery is expected to address these issues and …

Proton-driven transformable nanovaccine for cancer immunotherapy

N Gong, Y Zhang, X Teng, Y Wang, S Huo… - Nature …, 2020 - nature.com
Cancer vaccines hold great promise for improved cancer treatment. However, endosomal
trapping and low immunogenicity of tumour antigens usually limit the efficiency of vaccination …

Superior penetration and retention behavior of 50 nm gold nanoparticles in tumors

S Huo, H Ma, K Huang, J Liu, T Wei, S Jin, J Zhang… - Cancer research, 2013 - AACR
Nanoparticles offer potential as drug delivery systems for chemotherapeutics based on
certain advantages of molecular drugs. In this study, we report that particle size exerts great …

Mechanochemical bond scission for the activation of drugs

S Huo, P Zhao, Z Shi, M Zou, X Yang, E Warszawik… - Nature …, 2021 - nature.com
Pharmaceutical drug therapy is often hindered by issues caused by poor drug selectivity,
including unwanted side effects and drug resistance. Spatial and temporal control over drug …

Ultrasound‐controlled drug release and drug activation for cancer therapy

L Tu, Z Liao, Z Luo, YL Wu, A Herrmann, S Huo - Exploration, 2021 - Wiley Online Library
Traditional chemotherapy suffers from severe toxicity and side effects that limit its maximum
application in cancer therapy. To overcome this challenge, an ideal treatment strategy would …